Your browser doesn't support javascript.
loading
Defining textbook outcome for selective internal radiation therapy of hepatocellular carcinoma: an international expert study.
Gregory, Jules; Tselikas, Lambros; Allimant, Caroline; de Baere, Thierry; Bargellini, Irene; Bell, Jon; Bilbao, José Ignacio; Bouvier, Antoine; Chapiro, Julius; Chiesa, Carlo; Decaens, Thomas; Denys, Alban; Duran, Rafael; Edeline, Julien; Garin, Etienne; Ghelfi, Julien; Helmberger, Thomas; Irani, Farah; Lam, Marnix; Lewandowski, Robert; Liu, David; Loffroy, Romaric; Madoff, David C; Mastier, Charles; Salem, Riad; Sangro, Bruno; Sze, Daniel; Vilgrain, Valérie; Vouche, Michael; Guiu, Boris; Ronot, Maxime.
Afiliação
  • Gregory J; Centre de Recherche de L'Inflammation (CRI), Université Paris Cité, INSERM U1149, Paris, France. jules.gregory@aphp.fr.
  • Tselikas L; Department of Radiology, APHP Nord, Hôpital Beaujon, Clichy, France. jules.gregory@aphp.fr.
  • Allimant C; FHU MOSAIC, APHP, Paris, France. jules.gregory@aphp.fr.
  • de Baere T; Centre of Research in Epidemiology and Statistics (CRESS), Université Paris Cité, Inserm, INRAE, Paris, France. jules.gregory@aphp.fr.
  • Bargellini I; Institut Gustave Roussy, Villejuif, France.
  • Bell J; CHU Saint Eloi, Montpellier, France.
  • Bilbao JI; Institut Gustave Roussy, Villejuif, France.
  • Bouvier A; Pisa University Hospital, Pisa, Italy.
  • Chapiro J; The Christie National Health Service Foundation Trust, Manchester, UK.
  • Chiesa C; Clínica Universidad de Navarra, Pamplona, Spain.
  • Decaens T; CHU Angers, Angers, France.
  • Denys A; Yale University School of Medicine, New Haven, USA.
  • Duran R; Foundation IRCCS Istituto Nazionale Tumori, Milan, Italy.
  • Edeline J; CHU Grenoble Alpes, Grenoble, France.
  • Garin E; CHU Vaudois, Lausanne, Switzerland.
  • Ghelfi J; CHU Vaudois, Lausanne, Switzerland.
  • Helmberger T; Centre Eugène Marquis, Rennes, France.
  • Irani F; CHU Pontchaillou, Rennes, France.
  • Lam M; CHU Grenoble Alpes, Grenoble, France.
  • Lewandowski R; Klinikum Bogenhausen, Munich, Germany.
  • Liu D; Singapore General Hospital, Singapore, Singapore.
  • Loffroy R; University Medical Center, Utrecht, Netherlands.
  • Madoff DC; Northwestern Memorial Hospital, Chicago, USA.
  • Mastier C; Vancouver General Hospital, Vancouver, Canada.
  • Salem R; CHU François Mitterand, Dijon, France.
  • Sangro B; Yale University School of Medicine, New Haven, USA.
  • Sze D; Centre Leon Bérard, Lyon, France.
  • Vilgrain V; Northwestern Memorial Hospital, Chicago, USA.
  • Vouche M; Clínica Universidad de Navarra-CCUN and CIBEREHD, Pamplona, Spain.
  • Guiu B; Stanford University, Stanford, USA.
  • Ronot M; Centre de Recherche de L'Inflammation (CRI), Université Paris Cité, INSERM U1149, Paris, France.
Eur J Nucl Med Mol Imaging ; 50(3): 921-928, 2023 02.
Article em En | MEDLINE | ID: mdl-36282299
BACKGROUND: A textbook outcome (TO) is a composite indicator covering the entire intervention process in order to reflect the "ideal" intervention and be a surrogate for patient important outcomes. Selective internal radiation therapy (SIRT) is a complex multidisciplinary and multistep intervention facing the challenge of standardization. This expert opinion-based study aimed to define a TO for SIRT of hepatocellular carcinoma. METHODS: This study involved two steps: (1) the steering committee (4 interventional radiologists) first developed an extensive list of possible relevant items reflecting an optimal SIRT intervention based on a literature review and (2) then conducted an international and multidisciplinary survey which resulted in the final TO. This survey was online, from February to July 2021, and consisted three consecutive rounds with predefined settings. Experts were identified by contacting senior authors of randomized trials, large observational studies, or studies on quality improvement in SIRT. This study was strictly academic. RESULTS: A total of 50 items were included in the first round of the survey. A total of 29/40 experts (73%) responded, including 23 interventional radiologists (79%), three nuclear medicine physicians (10%), two hepatologists, and one oncologist, from 11 countries spanning three continents. The final TO consisted 11 parameters across six domains ("pre-intervention workup," "tumor targeting and dosimetry," "intervention," "post-90Y imaging," "length of hospital stay," and "complications"). Of these, all but one were applied in the institutions of > 80% of experts. CONCLUSIONS: This multidimensional indicator is a comprehensive standardization tool, suitable for routine care, clinical round, and research.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma Hepatocelular / Neoplasias Hepáticas Tipo de estudo: Clinical_trials / Observational_studies / Systematic_reviews Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article